Leandro Hermida

4PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 24, 2022
Predicting cancer prognosis and drug response from the tumor microbiome.

Leandro C Hermida, E Michael Gertz, Eytan Ruppin

|Sep 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.

Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao

|Mar 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanoma.

Shelly Kalaora, Adi Nagler, Deborah Nejman

|Sep 10, 2020
Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade.

Liangliang Wang, Yan Gao, Gao Zhang

Pageof 1